Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Rhea-AI Summary

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS) will present at the 23rd Annual Needham Virtual Healthcare Conference. The presentation by CEO Paul R. Edick aims to provide an overview of the company's innovative products. Interested parties can access the presentation on April 9, 2024, at 11:00 am Eastern Time through the investor relations page of Xeris' website.

CHICAGO--(BUSINESS WIRE)-- Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a range of therapies, today announced that Paul R. Edick, Xeris’ Chairman and CEO, will present an overview of the Company at the 23rd Annual Needham Virtual Healthcare Conference on Tuesday, April 9, 2024 at 11:00 am Eastern Time. To access the presentation, please visit “Events” on the investor relations page of the Company’s website at www.xerispharma.com.

About Xeris

Xeris (Nasdaq: XERS) is a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a range of therapies. Xeris has three commercially available products; Gvoke®, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia, Keveyis®, a proven therapy for primary periodic paralysis, and Recorlev® for the treatment of endogenous Cushing’s syndrome. Xeris also has a robust pipeline of development programs to extend the current marketed products into important new indications and uses and bring new products forward using its proprietary formulation technology platforms, XeriSol™ and XeriJect®, supporting long-term product development and commercial success.

Xeris Biopharma Holdings is headquartered in Chicago, IL. For more information, visit www.xerispharma.com, or follow us on X, LinkedIn, or Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240402611352/en/

Investor Contact

Allison Wey

Senior Vice President, Investor Relations and Corporate Communications

awey@xerispharma.com

Source: Xeris Biopharma Holdings, Inc.

FAQ

When will Xeris Biopharma present at the 23rd Annual Needham Virtual Healthcare Conference?

Xeris Biopharma will present at the 23rd Annual Needham Virtual Healthcare Conference on Tuesday, April 9, 2024, at 11:00 am Eastern Time.

Who will be presenting the overview of Xeris Biopharma at the conference?

Paul R. Edick, Xeris' Chairman and CEO, will present an overview of the company at the 23rd Annual Needham Virtual Healthcare Conference.

Where can interested parties access the presentation?

Interested parties can access the presentation on the investor relations page of Xeris' website at www.xerispharma.com.